W Miami Hotel

GOAT HOSPITALITY GROUP TAPPED AS W MIAMI'S OFFICIAL FOOD AND BEVERAGE PARTNER

Retrieved on: 
Wednesday, December 13, 2023
Wabi-sabi, Queen, Creativity, Aunt, Food, Nature, Heart, Down syndrome, Partnership, Development, Memory, Restaurant, Hotel, Nightclub, W Miami Hotel

MIAMI , Dec. 13, 2023 /PRNewswire/ -- Goat Hospitality Group, one of South Florida's ascending hospitality companies, announces its partnership with W Miami, the urban oasis located in the heart of the downtown's trendy Brickell District. Goat Hospitality takes the helm of the luxury hotel's food and beverage program.

Key Points: 
  • Goat Hospitality takes the helm of the luxury hotel's food and beverage program.
  • Goat Hospitality now oversees the hotel's entire food and beverage program, which currently includes the 15th-floor full-service rooftop restaurant ADDiKT, two-acre pool deck, Icon Café (now Cafe Icon by Goat Hospitality), events and catering, and in-room dining.
  • "We are thrilled to be collaborating with Goat Hospitality Group and offering our hotel guests the ultimate food and beverage experience," says Kashmira Maneckji, General Manager of W Miami.
  • Today, Goat Hospitality Group remains one of South Florida's largest employers for individuals with special abilities in the hospitality sector.

Spero Therapeutics to Present at Upcoming November Investor Conferences

Retrieved on: 
Wednesday, November 1, 2023
W Miami Hotel, Rare, Evercore, MDR, Conference, Infection, Lotte New York Palace Hotel, Kimpton, Spero, Therapy, Pharmaceutical industry, Online shopping

CAMBRIDGE, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that Sath Shukla, President and Chief Executive Officer, will be available for one-on-one meetings at the Truist Securities BioPharma Symposium, to be held at the Lotte New York Palace in New York, NY, on November 8-9, 2023 and will present and be available for one-on-one meetings at the 6th Annual Evercore ISI HealthCONx Conference to be held at the Kimpton EPIC Miami Hotel in Miami, FL, on November 28-30, 2023.

Key Points: 
  • CAMBRIDGE, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that Sath Shukla, President and Chief Executive Officer, will be available for one-on-one meetings at the Truist Securities BioPharma Symposium, to be held at the Lotte New York Palace in New York, NY, on November 8-9, 2023 and will present and be available for one-on-one meetings at the 6th Annual Evercore ISI HealthCONx Conference to be held at the Kimpton EPIC Miami Hotel in Miami, FL, on November 28-30, 2023.
  • Details are as follows:
    The webcast for the Evercore ISI event may also be accessed through Spero Therapeutics’ website ( www.sperotherapeutics.com ) on the “Events and Presentations” page under the “Connect” tab.
  • Replays will be available on the website following the conclusion of each event.